Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Low-dose Interferon alfa-2a on perioperative immune suppression
2020-004567-11Phase 2Active
- Sponsor
- Zealand University Hospital
- Start
- Sep 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in colon cancer comparing Pegylated interferon alfa-2a pre-operative with Placebo pre-operative (2 arms). Started Sep 2020; status: active.
02
Drugs
interferon alfa
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2020-004567-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004567-11.